22-OR: Nasal Glucagon: A Viable Alternative to Treat Insulin-Induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes

MUNEHIDE MATSUHISA; YASUSHI TAKITA; RISA NASU; KENJI OHWAKI; HIROTAKA NAGASHIMA

doi:10.2337/db19-22-or

22-OR: Nasal Glucagon: A Viable Alternative to Treat Insulin-Induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes

Diabetes ◽

10.2337/db19-22-or ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 22-OR

Author(s):

MUNEHIDE MATSUHISA ◽

YASUSHI TAKITA ◽

RISA NASU ◽

KENJI OHWAKI ◽

HIROTAKA NAGASHIMA

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Viable Alternative

Review for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v2/review1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Phase 3 ◽

Randomized Crossover Study

Decision letter for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Phase 3 ◽

Randomized Crossover Study

Author response for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v3/response1 ◽

2020 ◽

Author(s):

Munehide Matsuhisa ◽

Yasushi Takita ◽

Risa Nasu ◽

Yukiko Nagai ◽

Kenji Ohwaki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Author Response ◽

Phase 3 ◽

Randomized Crossover Study

Author response for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v2/response1 ◽

2020 ◽

Author(s):

Munehide Matsuhisa ◽

Yasushi Takita ◽

Risa Nasu ◽

Yukiko Nagai ◽

Kenji Ohwaki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Author Response ◽

Phase 3 ◽

Randomized Crossover Study

Review for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Phase 3 ◽

Randomized Crossover Study

Nasal glucagon as a viable alternative for treating insulin‐induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study

Diabetes Obesity and Metabolism ◽

10.1111/dom.14019 ◽

2020 ◽

Vol 22 (7) ◽

pp. 1167-1175 ◽

Cited By ~ 1

Author(s):

Munehide Matsuhisa ◽

Yasushi Takita ◽

Risa Nasu ◽

Yukiko Nagai ◽

Kenji Ohwaki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Phase 3 ◽

Randomized Crossover Study

Decision letter for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Phase 3 ◽

Randomized Crossover Study

Decision letter for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v3/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Phase 3 ◽

Randomized Crossover Study

Review for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v2/review2 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Phase 3 ◽

Randomized Crossover Study

Review for "Nasal Glucagon as a Viable Alternative to Treat Insulin‐induced Hypoglycemia in Japanese Patients with Type 1 and Type 2 Diabetes: A Phase 3 Randomized Crossover Study"

10.1111/dom.14019/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Crossover Study ◽

Japanese Patients ◽

Viable Alternative ◽

Phase 3 ◽

Randomized Crossover Study